The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

IART FINANCIAL STATEMENTS

Integra LifeSciences Holdings — balance sheet, income statement and cash flow trends

IARTIntegra LifeSciences Holdings

🇺🇸 USA · NASDAQ · Healthcare · Medical Devices

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
01 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue1.6 B $Gross Profit885.5 M $ · 54%Operating Income655.9 M $ · 40%Pre-tax Income-179 K $ · -0%Net Income to Owners-7.2 M $ · -0%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue1.6 B $+1.6%
Gross Profit885.5 M $+3.8%
Operating Income655.9 M $—
EBITDA248.8 M $—
Net Income to Owners-7.2 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
02 B4 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets3.6 B
  • Equity1.1 B $29%
  • Current Liabilities346.8 M $10%
  • Long-term Liabilities2.2 B $61%

Key Figures

YoY change
Total Assets3.6 B $-2.2%
Total Liabilities2.5 B $-3.6%
Total Equity1.1 B $+1.2%
Cash & ST Investments274.1 M $+8.1%
Total Debt2 B $+1.3%
Net Debt1.8 B $+1.6%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0200 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
050 M85.3 M $Operating-108.6 M $Investing20.8 M $Financing-2.5 M $Net Change

Key Figures

YoY change
Operating Cash Flow85.3 M $+20.4%
Capital Expenditures76.3 M $-35.5%
Free Cash Flow38.8 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on IART

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.